Lupin Limited has informed the Exchange regarding a press release dated November 17, 2023, titled "Lupin Receives Approval from U.S. FDA for Ganirelix Acetate Injection.".
Lupin Limited has informed the Exchange regarding a press release dated November 17, 2023, titled "Lupin Receives Approval from U.S. FDA for Ganirelix Acetate Injection.".